Patents by Inventor Yutong Jiang

Yutong Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide inhibitors of hepatitis C virus replication
    Patent number: 7932277
    Abstract: The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: April 26, 2011
    Assignees: InterMune, Inc., Array Biopharma Inc.
    Inventors: Scott Seiwert, Steven W. Andrews, Leonid Beigelman, Lawrence M. Blatt, Brad Buckman, Kevin R. Condroski, Yutong Jiang, Robert J. Kaus, April L. Kennedy, Timothy S. Kercher, Michael A. Lyon, Bin Wang
  • Macrocyclic inhibitors of hepatitis C virus replication
    Patent number: 7829665
    Abstract: The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: November 9, 2010
    Assignee: InterMune, Inc.
    Inventors: Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett, C. Todd Eary, Robert Kaus, Timothy Kercher, Weidong Liu, Michael Lyon, Paul Nichols, Bin Wang, Tarek Sammakia, April Kennedy, Yutong Jiang
  • NOVEL PEPTIDE INHIBITORS OF HEPATITIS C VIRUS REPLICATION
    Publication number: 20090297476
    Abstract: The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: May 9, 2008
    Publication date: December 3, 2009
    Applicants: InterMune, Inc., Array Biopharma Inc.
    Inventors: SCOTT SEIWERT, STEVEN W. ANDREWS, LEONID BEIGELMAN, LAWRENCE M. BLATT, BRAD BUCKMAN, Kevin R. Condroski, Yutong Jiang, Robert J. Kaus, April L. Kennedy, Timonthy S. Kercher, Michael A. Lyon, Bin Wang
  • MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
    Publication number: 20090286843
    Abstract: The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: October 20, 2008
    Publication date: November 19, 2009
    Inventors: LAWRENCE M. BLATT, STEVEN W. ANDREWS, KEVIN R. CONDROSKI, GEORGE A. DOHERTY, YUTONG JIANG, JOHN A. JOSEY, APRIL L. KENNEDY, MACHENDER R. MADDURU, PETER J. STENGEL, STEVEN M. WENGLOWSKY, BENJAMIN T. WOODARD, LAURA WOODARD
  • NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
    Publication number: 20090169510
    Abstract: The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: April 18, 2008
    Publication date: July 2, 2009
    Applicants: InterMune, Inc., Array BioPharma, Inc.
    Inventors: Lawrence M Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett, C. Todd Eary, Robert Kaus, Timothy Kercher, Weidong Liu, Michael Lyon, Paul Nichols, Bin Wang, Tarek Sammakia, April Kennedy, Yutong Jiang
  • NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
    Publication number: 20090155209
    Abstract: The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: May 2, 2008
    Publication date: June 18, 2009
    Inventors: LAWRENCE M. BLATT, LIN PAN, SCOTT SEIWERT, PIERRE MARTIN, ANDREAS SCHUMACHER, LEONID BEIGELMAN, JYANWEI LIU, STEVEN W. ANDREWS, KEVIN R. CONDROSKI, YUTONG JIANG, ROBERT J. KAUS, APRIL L. KENNEDY, TIMOTHY S. KERCHER, MICHAEL A. LYON, BIN WANG
  • Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
    Publication number: 20090148407
    Abstract: The embodiments provide compounds of the general Formulae (I) through general Formula (VIII), as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: July 17, 2006
    Publication date: June 11, 2009
    Applicants: Intermune, Inc., Array Biopharma Inc.
    Inventors: Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett, C. Todd Eary, Robert Kaus, Timothy Kercher, Weidong Liu, Michael Lyon, Paul Nichols, Bin Wang, Tarek Sammakia, April Kennedy, Yutong Jiang
  • MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
    Publication number: 20090111982
    Abstract: The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 30, 2009
    Inventors: Lawrence M. Blatt, Steven W. Andrews, Kevin R. Condroski, George A. Doherty, Yutong Jiang, John A. Josey, April L. Kennedy, Machender R. Madduru, Peter J. Stengel, Steven M. Wenglowsky, Benjamin T. Woodard, Laura Woodard
  • MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
    Publication number: 20090111969
    Abstract: The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 30, 2009
    Inventors: Lawrence M. Blatt, Steven W. Andrews, Kevin R. Condroski, George A. Doherty, Yutong Jiang, John A. Josey, April L. Kennedy, Machender R. Madduru, Peter J. Stengel, Steven M. Wenglowsky, Benjamin T. Woodard, Laura Woodard
  • MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
    Publication number: 20090105471
    Abstract: The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 23, 2009
    Inventors: Lawrence M. Blatt, Steven W. Andrews, Kevin R. Condroski, George A. Doherty, Yutong Jiang, John A. Josey, April L. Kennedy, Machender R. Madduru, Peter J. Stengel, Steven M. Wenglowsky, Benjamin T. Woodard, Laura Woodard
  • Macrocyclic compounds as inhibitors of viral replication
    Patent number: 7491794
    Abstract: The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: February 17, 2009
    Assignee: Intermune, Inc.
    Inventors: Lawrence M. Blatt, Steven W. Andrews, Kevin R. Condroski, Yutong Jiang, April L. Kennedy, Peter J. Stengel, Steven M. Wenglowsky
  • Novel macrocyclic inhibitors of hepatitis C virus replication
    Publication number: 20070054842
    Abstract: The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: July 21, 2006
    Publication date: March 8, 2007
    Inventors: Lawrence Blatt, Scott Seiwert, Steven Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett, C. Eary, Robert Kaus, Timothy Kercher, Weidong Liu, Michael Lyon, Paul Nichols, Bin Wang, Tarek Sammakia, April Kennedy, Yutong Jiang
  • Macrocyclic compounds as inhibitors of viral replication
    Publication number: 20050267018
    Abstract: The embodiments provide compounds of the general formulas I-XIX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating flaviviral infection, including hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    Type: Application
    Filed: March 29, 2005
    Publication date: December 1, 2005
    Inventors: Lawrence Blatt, Steven Andrews, Kevin Condroski, George Doherty, Yutong Jiang, John Josey, April Kennedy, Machender Madduru, Peter Stengel, Steven Wenglowsky, Benjamin Woodard, Laura Woodard